Unknown PHASE1 INTERVENTIONAL 2-arm NCT03438955

Phase I Drug-drug Interaction of Omega-3 and Atorvastatin

A Two-cohort, Single-sequence, Parallel, Open Label, Multiple Oral Dosing Phase I Study to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Omega-3 and Atorvastatin in Healthy Male Volunteers

Sponsor: DongKoo Bio & Pharma

Conditions Hyperlipidemia, Hypertriglyceridemia

Interventions Omacor Omacor + Pritor Pritor Pritor + Omacor

Updated 7 times since 2018 Last updated: Feb 20, 2018 Started: Feb 1, 2018 Primary completion: Jul 31, 2018 Completion: Aug 31, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Hyperlipidemia, Hypertriglyceridemia, this trial is ongoing. The trial is conducted by DongKoo Bio & Pharma and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE1
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Mar 2020 — Jan 2021 [monthly]

Unknown Status PHASE1

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Mar 2020 [monthly]

Recruiting PHASE1
Mar 2018 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Feb 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

DongKoo Bio & Pharma

Data source: DongKoo Bio & Pharma

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Busan, South Korea